Genetic Clues Unlock Mysteries of Restless Legs Syndrome
A study has identified over 140 new genetic risk factors for restless legs syndrome, increasing the total to 164.
A study has identified over 140 new genetic risk factors for restless legs syndrome, increasing the total to 164.
The device is indicated to reduce symptoms of primary moderate-severe restless legs syndrome and improve sleep quality in adults refractory to medications.
Twenty percent of restless legs syndrome patients are already on higher-than-recommended doses of dopamine agonists, says John Winkelman, MD, PhD.
Azurity Pharmaceuticals Inc has acquired Arbor Pharmaceuticals Inc, marketers of the restless legs syndrome drug Horizant.
New York Times: Some experts say tooth-grinding is a behavior rather than a disorder, and the dentist’s chair isn’t the best place to address it.
A study finds that when excessive wake time occurs with OSA or periodic limb movements, it is in fact an independent disorder related to abnormal central control of sleep depth.
Sleep medicine professionals can handle increased fourth-quarter patient demand for sleep studies by implementing strategies now.